Skip to main content
Category

Liver Disease

CancerCancerFundingImmunotherapyLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsResearch

Predicting immunotherapy effectiveness in late-stage liver cancer

By | Cancer, Cancer, Funding, Immunotherapy, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research

Blood test could hold key to identifying who will respond to immunotherapy after researchers discover biomarkers in liver cancer tissue. Liver cancer researchers at the Harry Perkins Institute of Medical…

awardsCancerCancerFundingLiverLiver CancerLiver CancerLiver DiseaseLiver DiseaseNews & EventsOncofetal Ecosystem

NHMRC funding for DEFINER to identify “the right drug for the right patient” in liver cancer

By | awards, Cancer, Cancer, Funding, Liver, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Oncofetal Ecosystem

The Harry Perkins Institute's Oncofetal Ecosystem Laboratory, established early in 2021, has received its first NHMRC Ideas Grant in the most recent grants round. This collaborative project run by the…

Disease AreaLabLiver DiseaseMitochondrial Medicine and BiologyMolecular MedicineNews & EventsResearchResearch Area

Mitochondria link to Fatty Liver Disease

By | Disease Area, Lab, Liver Disease, Mitochondrial Medicine and Biology, Molecular Medicine, News & Events, Research, Research Area

Perkins researcher, Dr Tara Richman from the Mitochondrial Medicine and Biology Laboratory, was lead author on the paper Mutation in MRPS34 Compromises Protein Synthesis and Causes Mitochondrial Dysfunction, recently accepted…